<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health Technology Collaboration | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/health-technology-collaboration/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Mon, 09 Nov 2026 13:23:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Health Technology Collaboration | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>mTuitive &#038; AIRA Matrix Partner to Connect AIRAProstate AI-powered Digital Pathology with Structured Pathology Reporting</title>
		<link>https://tissuepathology.com/2026/11/09/mtuitive-aira-matrix-partner-to-connect-airaprostate-ai-powered-digital-pathology-with-structured-pathology-reporting/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 09 Nov 2026 13:23:20 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[AIRA MATRIX]]></category>
		<category><![CDATA[clinical reports]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[mTuitive]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[prostate cancer]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24787</guid>

					<description><![CDATA[<p>Integration brings AIRAProstate AI findings directly into mTuitive synoptic reports, now available to explore in the CAP AI Studio. CENTERVILLE, MA, UNITED STATES, October 29, 2026 /EINPresswire.com/ &#8212; mTuitive, a leader in synoptic pathology reporting and structured cancer data capture, and AIRA Matrix, a provider of AI-powered digital pathology solutions, today announced a partnership that [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/11/09/mtuitive-aira-matrix-partner-to-connect-airaprostate-ai-powered-digital-pathology-with-structured-pathology-reporting/">mTuitive & AIRA Matrix Partner to Connect AIRAProstate AI-powered Digital Pathology with Structured Pathology Reporting</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Agilent Completes Acquisition of Proscia</title>
		<link>https://tissuepathology.com/2026/11/05/agilent-completes-acquisition-of-proscia/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 05 Nov 2026 13:12:24 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[acquisitio]]></category>
		<category><![CDATA[Agilent]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Proscia]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24782</guid>

					<description><![CDATA[<p>Agilent: Expands Agilent’s pathology portfolio and establishes a platform for scientific intelligence in tissue-based precision medicine Strengthens Agilent’s ability to support customers across clinical diagnostics, biopharma and life-sciences research SANTA CLARA, Calif., November 04, 2026 &#8212; Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Proscia®, a leading [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/11/05/agilent-completes-acquisition-of-proscia/">Agilent Completes Acquisition of Proscia</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia to Collaborate with Columbia University on Biomarker Discovery for Neurodegenerative Diseases</title>
		<link>https://tissuepathology.com/2026/10/28/proscia-to-collaborate-with-columbia-university-on-biomarker-discovery-for-neurodegenerative-diseases/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 28 Oct 2026 12:51:31 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Biomarker Discovery]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[Columbia University]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Proscia]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24765</guid>

					<description><![CDATA[<p>Philadelphia &#8211; October 27, 2026 &#8211; Proscia has entered into a collaborative agreement with Columbia University to identify biomarkers for neurodegenerative diseases, such as Alzheimer’s and other dementias. The collaboration pairs Columbia’s pathology leadership and digital slide repository with Proscia’s deep pathology AI expertise. “Collaborating with Proscia will enable us to leverage numerous data streams [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/28/proscia-to-collaborate-with-columbia-university-on-biomarker-discovery-for-neurodegenerative-diseases/">Proscia to Collaborate with Columbia University on Biomarker Discovery for Neurodegenerative Diseases</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development</title>
		<link>https://tissuepathology.com/2026/10/26/lunit-and-summit-therapeutics-announce-agreement-to-apply-ai-powered-scope-io-platform-for-tumor-microenvironment-analysis-in-immuno-oncology-development/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 26 Oct 2026 12:38:46 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Agreement]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[hematoxylin and eosin-stained (H&E)]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Immuno-oncology]]></category>
		<category><![CDATA[Ivonescimab]]></category>
		<category><![CDATA[Lunit]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Summit Therapeutics]]></category>
		<category><![CDATA[Tumor Microenvironment]]></category>
		<category><![CDATA[Whole Slide Images]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24759</guid>

					<description><![CDATA[<p>Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&#38;E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida, October 23, 2026 – Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a research agreement to evaluate the use of Lunit [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/26/lunit-and-summit-therapeutics-announce-agreement-to-apply-ai-powered-scope-io-platform-for-tumor-microenvironment-analysis-in-immuno-oncology-development/">Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>HistoIndex and A*STAR Partner To Advance Early – Stage Development Of Pipeline Therapies For Fibrotic Diseases</title>
		<link>https://tissuepathology.com/2026/10/20/histoindex-and-astar-partner-to-advance-early-stage-development-of-pipeline-therapies-for-fibrotic-diseases/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 20 Oct 2026 12:52:38 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[A*STAR]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[cancer-associated fibrosis]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Fibrotic Diseases]]></category>
		<category><![CDATA[Histoindex]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[research and development]]></category>
		<category><![CDATA[Singapore]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24747</guid>

					<description><![CDATA[<p>[SINGAPORE, October 19th, 2026] – /PR Newswire/ HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&#38;D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the preclinical evaluation and characterization of therapeutic candidates for various fibrotic diseases, including [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/20/histoindex-and-astar-partner-to-advance-early-stage-development-of-pipeline-therapies-for-fibrotic-diseases/">HistoIndex and A*STAR Partner To Advance Early – Stage Development Of Pipeline Therapies For Fibrotic Diseases</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership</title>
		<link>https://tissuepathology.com/2026/10/16/indica-labs-and-neogenomics-expand-ai-leadership-through-enterprise-digital-pathology-partnership/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 16 Oct 2026 11:41:44 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24740</guid>

					<description><![CDATA[<p>ALBUQUERQUE, N.M, October 15, 2026 — Indica Labs, the trusted global leader in AI-powered digital pathology, today announced a significant expansion of its strategic partnership with NeoGenomics, a leading provider of oncology diagnostic solutions that enable precision medicine. The expanded collaboration is intended to modernize NeoGenomics enterprise digital pathology infrastructure, accelerate the evaluation and adoption [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/16/indica-labs-and-neogenomics-expand-ai-leadership-through-enterprise-digital-pathology-partnership/">Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
